Generation Bio Co. (GBIO)

Generation Bio Co. Market Cap

Generation Bio Co. has a market cap or net worth of $242.16 million as of May 17, 2024. Its market cap has decreased by -19.49% in one year.

• Market Cap: 242.16M
• Enterprise Value: 116.62M
• 1-Year Change: -19.49%
• Ranking: #3535
• Category: Micro-Cap
• Stock Price: $3.66

Market Cap Chart

Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.09B to $242.16M, a decrease of -77.76%. That is a compound annual growth rate of -31.78%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	243.50M	-2.91%
May 16, 2024	250.80M	-0.52%
May 15, 2024	252.10M	7.05%
May 14, 2024	235.50M	24.67%
May 13, 2024	188.90M	-4.98%
May 10, 2024	198.80M	-8.26%
May 9, 2024	216.70M	5.14%
May 8, 2024	206.10M	-2.51%
May 7, 2024	211.40M	-5.07%
May 6, 2024	222.70M	5.70%
May 3, 2024	210.70M	1.94%
May 2, 2024	206.70M	6.88%
May 1, 2024	193.40M	2.82%
Apr 30, 2024	188.10M	-0.74%
Apr 29, 2024	189.50M	-1.71%
Apr 26, 2024	192.80M	-3.65%
Apr 25, 2024	200.10M	0.65%
Apr 24, 2024	198.80M	-8.26%
Apr 23, 2024	216.70M	16.01%
Apr 22, 2024	186.80M	0.38%
Apr 19, 2024	186.10M	0.70%
Apr 18, 2024	184.80M	-6.71%
Apr 17, 2024	198.10M	-4.81%
Apr 16, 2024	208.10M	-15.41%
Apr 15, 2024	246.00M	-

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Utah Medical Products	245.44M
Pyxis Oncology	243.80M
uniQure	243.72M
Coherus BioSciences	242.65M
AngioDynamics	242.53M
Akebia Therapeutics	242.08M
Foghorn Therapeutics	235.92M
G1 Therapeutics	235.53M